Company Filing History:
Years Active: 2016
Title: Innovations in Cancer Treatment: The Work of Frederique Dol-Gleizes
Introduction
Frederique Dol-Gleizes is an accomplished inventor based in Toulouse, France, renowned for his contributions to the field of cancer treatment. With a focus on innovating therapeutic approaches, Dol-Gleizes has earned recognition for his significant work in developing new medical solutions, particularly in the area of protein research.
Latest Patents
Dol-Gleizes holds one patent entitled "Robo1-Fc fusion protein and use thereof for treating tumours." This groundbreaking invention pertains to a Robo1-Fc recombinant protein aimed at treating diseases, including cancers, where a Slit protein is overexpressed. Additionally, the patent highlights the potential of this recombinant protein as a diagnostic tool for detecting the overexpression of Slit family molecules in patients, showcasing the dual applicability of his innovation in both treatment and diagnosis.
Career Highlights
Frederique Dol-Gleizes works with Sanofi, a global leader in healthcare and pharmaceuticals. His position at the company allows him to collaborate effectively with other innovators and researchers, contributing to significant advancements in medical technology. Dol-Gleizes' commitment to researching and developing new therapeutic options underscores his important role in the field.
Collaborations
Throughout his career, Dol-Gleizes has collaborated with esteemed colleagues, including Francis Blanche and Beatrice Cameron. This multidisciplinary teamwork enhances the innovation process, bringing together diverse expertise to tackle complex medical challenges. Such collaborations are crucial in translating scientific research into effective treatments.
Conclusion
Frederique Dol-Gleizes exemplifies the spirit of innovation within the medical field. His patent on the Robo1-Fc fusion protein represents a significant step forward in the fight against cancer and other diseases. As he continues his work at Sanofi, Dol-Gleizes remains a pivotal figure in the advancement of medical science, inspiring future generations of inventors and researchers in their quest for novel treatments.